Find Suppliers & Manufacturers (CMO / CDMO) of Controlled & Modified Release Excipients For Tablet of Carbomer Homopolymer Type B

Please Wait

Applying Filters...

All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

FDA_Warning_Letters, Import_Alerts_&_EU_Non-Compliances_in_2019

X

pmc-isochem-Default-Wallpaper

pmc-isochem-Default-Wallpaper

Filters

×

FILTER DATA :

Company

All

Lubrizol Life Science Health

Country

All

UNITED STATES

Lubrizol Life Science Health

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States

Post An Enquiry

Drug Discovery Chemistry

Participation Not Confirmed

Update your events

Carbopol 974P NF

Supporting Information: Click here to upload a PDF

Link to Supplier Content

Contact the Supplier

Applications: Carbopol® 974P NF polymer is used in oral and mucosal contact applications such as oral liquids, bioadhesive formulations, & extended release tablets. Additionally, it can be used to formulate viscous gels, emulsions & suspensions.

Ingredient(s): Carbomer Homopolymer Type B

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral & Topical

Pharmacopoeia Reference: United States Pharmacopeia/National Formulary (USP/NF) monograph for Carbomer Homopolymer Type B, European Pharmacopeia (Ph. Eur.), India Pharmacopeia (IP), China Pharmacopeia (ChP) mongographs for Carbomers.

Technical Specifications: Viscosity, cP (0.5 wt% at pH 7.5)- 29,400 - 39,400

Market Place

Home

Menu

Post Enquiry

Market Place

Search